Intravenous cyclophosphamide-resistant systemic lupus erythematosus in Arizona

Pediatric Nephrology

Volumn 19, Issue 7, 2004, Pages 738-743

  Dixit, Mehul P ^a   Bracamonte, Erika ^a   Dixit, Naznin ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Bone marrow transplant; Cyclophosphamide resistant systemic lupus erythematosus; Immunosuppression; Outcome; Therapy

Indexed keywords

CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; HYDROXYCHLOROQUINE; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; PROTEIN;

ADOLESCENT; ARTICLE; BODY WEIGHT DISORDER; BONE MARROW TRANSPLANTATION; CHILD; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CREATININE CLEARANCE; DEATH; DIALYSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG RESPONSE; FEMALE; FOLLOW UP; HEMATURIA; HISPANIC; HUMAN; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; ONSET AGE; PRIORITY JOURNAL; PROTEINURIA; PULSATILE DRUG RELEASE; RELAPSE; REMISSION; SEX RATIO; SIDE EFFECT; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT FAILURE; TREATMENT OUTCOME; UNITED STATES; WEIGHT GAIN; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ARIZONA; CHILD; CYCLOPHOSPHAMIDE; DRUG RESISTANCE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAVENOUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; RETROSPECTIVE STUDIES;

EID: 3142771473     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-004-1496-y     Document Type: Article

References (38)

1. Flanc RS, Roberts MA, Strippoli GF, Chadban SJ, Kerr PG, Atkins RC (2004) Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trials. Am J Kidney Dis 43:197-208
2. Austin HA, Balow JE (1999) Natural history and treatment of lupus nephritis. Semin Nephrol 19:2-11
3. Austin HA, Balow JE (2000) Treatment of lupus nephritis. Semin Nephrol 20:265-276
4. Cameron JS (1999) Lupus nephritis. J Am Soc Nephrol 10:413-424
5. Bastian HM, Roseman JM, McGwin G Jr, Alarcon GS, Friedman AW, Fessler BJ, Baethge BA, Reveille JD (2002) Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis. Lupus 11:152-160
6. Tejani A, Nicastri AD, Chen CK, Fikrig S, Gurumurthy K (1983) Lupus nephritis in black and Hispanic children. Am J Dis Child 137:481-483
7. Niaudet P (2000) Treatment of lupus nephritis in children. Pediatr Nephrol 14:158-166
8. Klein-Gitelman M, Reiff A, Silverman ED (2002) Systemic lupus erythematosus in childhood. Rheum Dis Clin North Am 28:561-577
9. Dooley MA, Hogan S, Jennette C, Falk R (1997) Cyclophosphamide therapy for lupus nephritis: poor renal survival in black Americans. Glomerular Disease Collaborative Network. Kidney Int 51:1188-1195
10. Alarcon GS, McGwin G Jr, Petri M, Reveille JD, Ramsey-Goldman R, Kimberly RP (2002) Baseline characteristics of a multiethnic lupus cohort: PROFILE. Lupus 11:95-101
11. Alarcon GS, McGwin G, Jr., Bartolucci AA, Roseman J, Lisse J, Fessler BJ, Bastian HM, Friedman AW, Reveille JD (2001) Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual. Arthritis Rheum 44:2797-2806
12. Alarcon GS (2001) Of ethnicity, race and lupus. Lupus 10:594-596
13. Austin HA 3rd, Boumpas DT, Vaughan EM, Balow JE (1995) High-risk features of lupus nephritis: importance of race and clinical and histological factors in 166 patients. Nephrol Dial Transplant 10: 1620-1628
14. Ravelli A, Duarte-Salazar C, Buratti S, Reiff A, Bernstein B, Maldonado-Velazquez MR, Beristain-Manterola R, Maeno N, Takei S, Gerloni V, Spencer CH, Pratsidou-Gertsi P, Ruperto N, Pistorio A, Martini A (2003) Assessment of damage in juvenile-onset systemic lupus erythematosus: a multicenter cohort study. Arthritis Rheum 49:501-507
15. Buratti S, Szer IS, Spencer CH, Bartosh S, Reiff A (2001) Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus. J Rheumatol 28:2103-2108
16. Schwartz GJ, Gauthier B (1985) A simple estimate of glomerular filtration rate in adolescent boys. J Pediatr 106:522-526
17. Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41
18. Balow JE (2002) Choosing treatment for proliferative lupus nephritis. Arthritis Rheum 46:1981-1983
19. Valeri A, Radhakrishnan J, Estes D, D'Agati V, Kopelman R, Pernis A, Flis R, Pirani C, Appel GB (1994) Intravenous pulse cyclophosphamide treatment of severe lupus nephritis: a prospective five-year study. Clin Nephrol 42:71-78
20. Gourley MF, Austin HA 3rd, Scott D, Yarboro CH, Vaughan EM, Muir J, Boumpas DT, Klippel JH, Balow JE, Steinberg AD (1996) Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial. Ann Intern Med 125:549-557
21. Austin HA 3rd, Klippel JH, Balow JE, le Riche NG, Steinberg AD, Plotz PH, Decker JL (1986) Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med 314:614-619
22. Steinberg AD, Steinberg SC (1991) Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only. Arthritis Rheum 34:945-950
23. Balow JE, Austin HA 3rd (2004) Maintenance therapy for lupus nephritis - something old, something new. N Engl J Med 350:1044-1046
24. Balow JE, Austin HA 3rd (2004) Treatment of proliferative lupus nephritis. Am J Kidney Dis 43:383-385
25. Radhakrishnan J, Kunis CL, D'Agati V, Appel GB (1994) Cyclosporine treatment of lupus membranous nephropathy. Clin Nephrol 42:147-154
26. Klein M, Radhakrishnan J, Appel G (1999) Cyclosporine treatment of glomerular diseases. Annu Rev Med 50:1-15
27. Fu LW, Yang LY, Chen WP, Lin CY (1998) Clinical efficacy of cyclosporin a neoral in the treatment of paediatric lupus nephritis with heavy proteinuria. Br J Rheumatol 37:217-221
28. Baqi N, Moazami S, Singh A, Ahmad H, Balachandra S, Tejani A (1996) Lupus nephritis in children: a longitudinal study of prognostic factors and therapy. J Am Soc Nephrol 7:924-929
29. Gloor JM (1998) Lupus nephritis in children. Lupus 7:639-643
30. Hahn BH (1997) The potential role of autologous stem cell transplantation in patients with systemic lupus erythematosus. J Rheumatol [Suppl] 48:89-93
31. Burt RK, Traynor AE, Pope R, Schroeder J, Cohen B, Karlin KH, Lobeck L, Goolsby C, Rowlings P, Davis FA, Stefoski D, Terry C, Keever-Taylor C, Rosen S, Vesole D, Fishman M, Brush M, Mujias S, Villa M, Burns WH (1998) Treatment of autoimmune disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation. Blood 92:3505-3514
32. Escalante A, Rincon I del (2001) Epidemiology and impact of rheumatic disorders in the United States Hispanic population. Curr Opin Rheumatol 13:104-110
33. Walsh SJ, DeChello LM (2001) Geographical variation in mortality from systemic lupus erythematosus in the United States. Lupus 10:637-646
34. Bansal VK, Beto JA (1997) Treatment of lupus nephritis: a meta-analysis of clinical trials. Am J Kidney Dis 29:193-199
35. Contreras G, Pardo V, Leclercq B, Lenz O, Tozman E, O'Nan P, Roth D (2004) Sequential therapies for proliferative lupus nephritis. N Engl J Med 350:971-980
36. Mok CC, Ho CT, Chan KW, Lau CS, Wong RW (2002) Outcome and prognostic indicators of diffuse proliferative lupus glomerulonephritis treated with sequential oral cyclophosphamide and azathioprine. Arthritis Rheum 46:1003-1013
37. Mok CC, Wong RW, Lai KN (2003) Treatment of severe proliferative lupus nephritis: the current state. Ann Rheum Dis 62:799-804
38. Chan TM, Li FK, Tang CS, Wong RW, Fang GX, Ji YL, Lau CS, Wong AK, Tong MK, Chan KW, Lai KN (2000) Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group. N Engl J Med 343:1156-1162